Unit News
Showing items
through of articles.
-
Cronin named Occupational Therapy Interim Chair
Thursday, August 2, 2018
Anne Cronin, Ph.D., OTR/L, has been named interim chair of the Division of Occupational Therapy. Cronin is a longtime professor and an international leader in pediatric occupational therapy practice.Read Cronin named Occupational Therapy Interim Chair full story
-
Kolodney to chair new Dermatology Department
Thursday, August 2, 2018
Michael Kolodney, M.D., Ph.D., has been named to serve as chair of the newly formed Department of Dermatology.Read Kolodney to chair new Dermatology Department full story
-
WVU neuroscientist awarded for research in human-machine teaming
Monday, July 30, 2018
Victor Finomore, Ph.D., director of Human Performance and Applied Neuroscience at the WVU Rockefeller Neuroscience Institute and his previous team at the U.S. Air Force Academy received the 2018 Parasuraman Award for Scientific Impact at the second International Neuroergonomics Conference at Drexel University in June for their preliminary work on human-machine teaming and trust in automation.Read WVU neuroscientist awarded for research in human-machine teaming full story
-
Art in the Libraries series to debut in August
Monday, July 30, 2018
Art in the Libraries is an art exhibition program presenting exhibits in the WVU campus libraries. Opening August 1, at the Health Sciences Library, an exhibit of photographs by Rebecca Kiger that are a part of the A Knowing Intimacy exhibit will be on display.Read Art in the Libraries series to debut in August full story
-
West Virginia University selected as first site to launch an innovative clinical trial for Alzheimer’s
Thursday, July 26, 2018
West Virginia University (WVU) has been selected as the first site for an innovative clinical trial to treat Alzheimer’s disease. Ali Rezai, M.D., director of the WVU Rockefeller Neuroscience Institute, will lead the initiative in collaboration with INSIGHTEC, an Israel-based medical technology company who received approval by the U.S. Food and Drug Administration (FDA) to begin the clinical trial using focused ultrasound to treat Alzheimer’s.
